510(k) · Cleared
Recalled · 2006Autologous Blood Management System (Abms)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dideco S.P.A. · CAC Apparatus, Autotransfusion
Cleared on Dec 16, 1998 as substantially equivalent to K884564 (Shiley, Inc., 1989) and 4 other predicates after a 139-day review. Its family tree reaches back 1 generation to 1989. 8 later devices descend from it. It has been recalled 2 times.
- Decided
- Dec 16, 1998
- Review
- 139 days
- Class
- Class II
- Product code
- CAC
- Recalls
- 2
- Predicates
- 5
Its longest line of descent runs back 1 generation to K884564 (1989). 5 ancestors in all. 8 later devices descend from it, 3 citing it directly.
- Root · 1 generation backK884564 Shiley Therapeutic Autotransfusion System-ProgrammShiley, Inc. · 1989
- This deviceK982650 Autologous Blood Management System (Abms)Dideco S.P.A. · 1998
- Descendant · cites it directly · 7 of its ownK020647 Dideco ElectaDideco S.P.A. · 2002 · Recalled
- Descendant · 2 generations on · 5 of its ownK101586 Xtra Autotransfusion SystemSorin Group Italia S.R.L. · 2010
- Descendant · 3 generations on · 1 of its ownK112245 XTRASorin Group Italia S.R.L. · 2011
- Descendant · 3 generations on · 0 of its ownK241236 XTRA Collection sets; XTRA Sequestration set XSorin Group Italia S.R.L. · 2024
- Descendant · 3 generations on · 0 of its ownK240584 XTRA Autotransfusion System (with XTRA Bowl sets)Sorin Group Italia S.R.L. · 2024
Showing 5 of 8 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 8 · See all- K020647Dideco ElectaDideco S.P.A. · 2002 · cites it directly7descendants
- K101586Xtra Autotransfusion SystemSorin Group Italia S.R.L. · 2010 · 2 generations on5descendants
- K112245XTRASorin Group Italia S.R.L. · 2011 · 3 generations on1descendant
- K241236XTRA Collection sets; XTRA Sequestration set XSorin Group Italia S.R.L. · 2024 · 3 generations on0descendants
- K240584XTRA Autotransfusion System (with XTRA Bowl sets)Sorin Group Italia S.R.L. · 2024 · 3 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K884564 | Shiley Therapeutic Autotransfusion System-Programm | Shiley, Inc. | 1989 | — |
| 0 (this device) | K982650 | Autologous Blood Management System (Abms) | Dideco S.P.A. | 1998 | — |
| +1 | K020647 | Dideco Electa | Dideco S.P.A. | 2002 | 2 |
| +2 | K101586 | Xtra Autotransfusion System | Sorin Group Italia S.R.L. | 2010 | — |
| +3 | K112245 | XTRA | Sorin Group Italia S.R.L. | 2011 | — |
| +3 | K241236 | XTRA Collection sets; XTRA Sequestration set X | Sorin Group Italia S.R.L. | 2024 | — |
| +3 | K240584 | XTRA Autotransfusion System (with XTRA Bowl sets) | Sorin Group Italia S.R.L. | 2024 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1995 | 1 | 0 |
| 1998 | 2 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2002 | 1 | 0 |
| 2006 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 1 | 0 |
| 2014 | 1 | 0 |
| 2024 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new CAC device
- #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K884564 | Shiley Therapeutic Autotransfusion System-ProgrammSummary page 2…y Name: Autologous Blood Management System (ABMS) Common/Usual Name: Autotransfusion Device Classification Names: Autotransfusion Apparatus 3. PREDICATE DEVICES STAT-P K884564 Compact K910991 (under the name Shiley Therapeutic Autotransfusion System) Compact-A K940519 K963758 K963759 AT-1000 K Number c… | 1989 |
| * | K910991 | Shiley Therapeutic Autotransfusion SystemSummary page 2…us Blood Management System (ABMS) Common/Usual Name: Autotransfusion Device Classification Names: Autotransfusion Apparatus 3. PREDICATE DEVICES STAT-P K884564 Compact K910991 (under the name Shiley Therapeutic Autotransfusion System) Compact-A K940519 K963758 K963759 AT-1000 K Number could not be iden… | 1991 |
| * | K940519 | Dideco Compact-a Autotransfusion SystemSummary page 2…assification Names: Autotransfusion Apparatus 3. PREDICATE DEVICES STAT-P K884564 Compact K910991 (under the name Shiley Therapeutic Autotransfusion System) Compact-A K940519 K963758 K963759 AT-1000 K Number could not be identified 4, INTENDED USE The ABMS is indicated for intraoperative and postoper… | 1995 |
| * | K963758 | Code 150 Blood Component Collection Set and with Direct Draw LineSummary page 2…tion Names: Autotransfusion Apparatus 3. PREDICATE DEVICES STAT-P K884564 Compact K910991 (under the name Shiley Therapeutic Autotransfusion System) Compact-A K940519 K963758 K963759 AT-1000 K Number could not be identified 4, INTENDED USE The ABMS is indicated for intraoperative and postoperative re… | 1998 |
| * | K963759 | Dideco Compact-a and Compact-M Autotransfusion SystemsSummary page 2…es: Autotransfusion Apparatus 3. PREDICATE DEVICES STAT-P K884564 Compact K910991 (under the name Shiley Therapeutic Autotransfusion System) Compact-A K940519 K963758 K963759 AT-1000 K Number could not be identified 4, INTENDED USE The ABMS is indicated for intraoperative and postoperative recovery o… | 1998 |
| * | — | AT-1000 Named without a submission number |
What descends from it? (8)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Aug 4, 2006 | Not classified | Z-1490-06 | Other | Foreign particles-manufacturing error may lead to abrasion of bowl seal in blood recovery sets, possibly causing particles in the blood. |
| Aug 4, 2006 | Not classified | Z-1488-06 | Other | Foreign particles-manufacturing error may lead to abrasion of bowl seal in blood recovery sets, possibly causing particles in the blood. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 5 ancestors has a recall.
- Of its descendants, K020647 (Dideco S.P.A., 2002) has gone furthest, with 7 descendants of its own.
How does its category compare?
All CAC devicesCAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · CAC
3in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · CAC
91in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · CAC
7in 2023
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · CAC
128in 2025
MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 1 | 35 |
| 2008 | 1 | — | 5 | 12 |
| 2009 | 0 | — | 25 | 68 |
| 2010 | 4 | 123 | 3 | 115 |
| 2011 | 2 | — | 3 | 939 |
| 2012 | 3 | 90 | 0 | 249 |
| 2013 | 1 | — | 9 | 153 |
| 2014 | 3 | 269 | 0 | 90 |
| 2015 | 0 | — | 0 | 87 |
| 2016 | 2 | — | 0 | 73 |
| 2017 | 1 | — | 2 | 88 |
| 2018 | 2 | — | 2 | 87 |
| 2019 | 1 | — | 23 | 64 |
| 2020 | 1 | — | 0 | 108 |
| 2021 | 4 | 155 | 0 | 73 |
| 2022 | 1 | — | 0 | 65 |
| 2023 | 2 | — | 7 (2) | 39 |
| 2024 | 3 | 91 | 0 | 129 |
| 2025 | 0 | — | 0 | 128 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The ABMS is indicated for intraoperative recovery of blood, washing of blood collected in the post-operative period, and pre-operative sequestration (with indirect and direct patient connection). Typical clinical applications of autotransfusion include the following surgical specialties: Cardiovascular, Orthopedics, Thoracic, Transplant Surgery, Emergency (Trauma), Neurosurgery, Obstetrics and gynecology, Urology.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K982650 · printed Nov 4, 2026
Cite this page
510(k) Report. “K982650: Autologous Blood Management System (Abms).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K982650
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026